TD Asset Management
EDIT icon

TD Asset Management’s Editas Medicine EDIT Stock Holding History

TD Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,670
Closed -$236K – 1335
2019
Q1 		$236K Sell
9,670
-7,300
-43% -$165K ﹤0.01% 1295
2018
Q4 		$386K Sell
16,970
-4,000
-19% -$109K ﹤0.01% 1269
2018
Q3 		$667K Buy
20,970
+200
+1% +$6.46K ﹤0.01% 1236
2018
Q2 		$744K Buy
20,770
+300
+1% +$10.6K ﹤0.01% 1192
2018
Q1 		$679K Buy
20,470
+300
+1% +$10.7K ﹤0.01% 1142
2017
Q4 		$620K Sell
20,170
-8,600
-30% -$217K ﹤0.01% 1158
2017
Q3 		$691K Sell
28,770
-2,900
-9% -$55.2K ﹤0.01% 1119
2017
Q2 		$531K Sell
31,670
-2,100
-6% -$37.8K ﹤0.01% 1176
2017
Q1 		$754K Buy
33,770
+2,800
+9% +$58K ﹤0.01% 1109
2016
Q4 		$503K Hold
30,970
– – ﹤0.01% 1183
2016
Q3 		$417K Buy
30,970
+18,483
+148% +$379K ﹤0.01% 1227
2016
Q2 		$305K Hold
12,487
– – ﹤0.01% 1248
2016
Q1 		$431K Buy
+12,487
New +$328K ﹤0.01% 1137

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

TD Asset Management's EDIT Position: Q2 2019 in Review

TD Asset Management sold out of Editas Medicine (EDIT) in Q2 2019, closing a stake of 9,670 shares — an estimated $236K sold.

TD Asset Management first reported a position in EDIT in Q1 2016 and held it in 13 quarters. The position peaked at $754K in Q1 2017. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2019.

  • TD Asset Management reported no remaining Editas Medicine position as of Q2 2019 after selling out during the quarter.
  • TD Asset Management sold 9,670 Editas Medicine shares in Q2 2019, an estimated $236K.
  • TD Asset Management first reported a position in Editas Medicine in Q1 2016 and held it in 13 quarters.
  • TD Asset Management's Editas Medicine position peaked at $754K in Q1 2017.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2019.

Based on TD Asset Management's 13F filing for Q2 2019, filed 1 Aug 2019.